127 related articles for article (PubMed ID: 36736283)
1. Insights on hematopoietic cell kinase: An oncogenic player in human cancer.
Luo S; Du S; Tao M; Cao J; Cheng P
Biomed Pharmacother; 2023 Apr; 160():114339. PubMed ID: 36736283
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic cell kinase (HCK) as a therapeutic target in immune and cancer cells.
Poh AR; O'Donoghue RJ; Ernst M
Oncotarget; 2015 Jun; 6(18):15752-71. PubMed ID: 26087188
[TBL] [Abstract][Full Text] [Related]
3. Hematopoietic cell kinase (Hck) isoforms and phagocyte duties - from signaling and actin reorganization to migration and phagocytosis.
Guiet R; Poincloux R; Castandet J; Marois L; Labrousse A; Le Cabec V; Maridonneau-Parini I
Eur J Cell Biol; 2008 Sep; 87(8-9):527-42. PubMed ID: 18538446
[TBL] [Abstract][Full Text] [Related]
4. Identification of the SRC-family tyrosine kinase HCK as a therapeutic target in mantle cell lymphoma.
Lantermans HC; Minderman M; Kuil A; Kersten MJ; Pals ST; Spaargaren M
Leukemia; 2021 Mar; 35(3):881-886. PubMed ID: 32591642
[TBL] [Abstract][Full Text] [Related]
5. Selective targeting of the inactive state of hematopoietic cell kinase (Hck) with a stable curcumin derivative.
Chakraborty MP; Bhattacharyya S; Roy S; Bhattacharya I; Das R; Mukherjee A
J Biol Chem; 2021; 296():100449. PubMed ID: 33617879
[TBL] [Abstract][Full Text] [Related]
6. Regulation of p73 by Hck through kinase-dependent and independent mechanisms.
Paliwal P; Radha V; Swarup G
BMC Mol Biol; 2007 May; 8():45. PubMed ID: 17535448
[TBL] [Abstract][Full Text] [Related]
7. HCK promotes glioblastoma progression by TGFβ signaling.
Wang Z; Ying C; Zhang A; Xu H; Jiang Y; Lou M
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32484210
[TBL] [Abstract][Full Text] [Related]
8. The Src family kinase Hck regulates mast cell activation by suppressing an inhibitory Src family kinase Lyn.
Hong H; Kitaura J; Xiao W; Horejsi V; Ra C; Lowell CA; Kawakami Y; Kawakami T
Blood; 2007 Oct; 110(7):2511-9. PubMed ID: 17513616
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Hematopoietic Cell Kinase Activity Suppresses Myeloid Cell-Mediated Colon Cancer Progression.
Poh AR; Love CG; Masson F; Preaudet A; Tsui C; Whitehead L; Monard S; Khakham Y; Burstroem L; Lessene G; Sieber O; Lowell C; Putoczki TL; O'Donoghue RJJ; Ernst M
Cancer Cell; 2017 Apr; 31(4):563-575.e5. PubMed ID: 28399411
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic cell kinase (HCK) is a potential therapeutic target for dysplastic and leukemic cells due to integration of erythropoietin/PI3K pathway and regulation of erythropoiesis: HCK in erythropoietin/PI3K pathway.
Roversi FM; Pericole FV; Machado-Neto JA; da Silva Santos Duarte A; Longhini AL; Corrocher FA; Palodetto B; Ferro KP; Rosa RG; Baratti MO; Verjovski-Almeida S; Traina F; Molinari A; Botta M; Saad ST
Biochim Biophys Acta Mol Basis Dis; 2017 Feb; 1863(2):450-461. PubMed ID: 27840303
[TBL] [Abstract][Full Text] [Related]
11. Src family kinases, HCK and FGR, associate with local inflammation and tumour progression in colorectal cancer.
Roseweir AK; Powell AGMT; Horstman SL; Inthagard J; Park JH; McMillan DC; Horgan PG; Edwards J
Cell Signal; 2019 Apr; 56():15-22. PubMed ID: 30684564
[TBL] [Abstract][Full Text] [Related]
12. An inhibitor-resistant mutant of Hck protects CML cells against the antiproliferative and apoptotic effects of the broad-spectrum Src family kinase inhibitor A-419259.
Pene-Dumitrescu T; Peterson LF; Donato NJ; Smithgall TE
Oncogene; 2008 Nov; 27(56):7055-69. PubMed ID: 18794796
[TBL] [Abstract][Full Text] [Related]
13. The inhibition of SRC family kinase suppresses pancreatic cancer cell proliferation, migration, and invasion.
Je DW; O YM; Ji YG; Cho Y; Lee DH
Pancreas; 2014 Jul; 43(5):768-76. PubMed ID: 24763074
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation-dependent interactions between ADAM15 cytoplasmic domain and Src family protein-tyrosine kinases.
Poghosyan Z; Robbins SM; Houslay MD; Webster A; Murphy G; Edwards DR
J Biol Chem; 2002 Feb; 277(7):4999-5007. PubMed ID: 11741929
[TBL] [Abstract][Full Text] [Related]
15. Hck inhibitors as potential therapeutic agents in cancer and HIV infection.
Musumeci F; Schenone S; Brullo C; Desogus A; Botta L; Tintori C
Curr Med Chem; 2015; 22(13):1540-64. PubMed ID: 25666803
[TBL] [Abstract][Full Text] [Related]
16. Hck is a key regulator of gene expression in alternatively activated human monocytes.
Bhattacharjee A; Pal S; Feldman GM; Cathcart MK
J Biol Chem; 2011 Oct; 286(42):36709-23. PubMed ID: 21878628
[TBL] [Abstract][Full Text] [Related]
17. Transformation of myeloid leukemia cells to cytokine independence by Bcr-Abl is suppressed by kinase-defective Hck.
Lionberger JM; Wilson MB; Smithgall TE
J Biol Chem; 2000 Jun; 275(24):18581-5. PubMed ID: 10849448
[TBL] [Abstract][Full Text] [Related]
18. Differential involvement of Src family kinases in Fc gamma receptor-mediated phagocytosis.
Suzuki T; Kono H; Hirose N; Okada M; Yamamoto T; Yamamoto K; Honda Z
J Immunol; 2000 Jul; 165(1):473-82. PubMed ID: 10861086
[TBL] [Abstract][Full Text] [Related]
19. A beta 1 integrin signaling pathway involving Src-family kinases, Cbl and PI-3 kinase is required for macrophage spreading and migration.
Meng F; Lowell CA
EMBO J; 1998 Aug; 17(15):4391-403. PubMed ID: 9687507
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic cell kinase enhances osteosarcoma development via the MEK/ERK pathway.
Liu W; Li T; Hu W; Ji Q; Hu F; Wang Q; Yang X; Qi D; Chen H; Zhang X
J Cell Mol Med; 2021 Sep; 25(18):8789-8795. PubMed ID: 34363435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]